$1.51
-0.02 (-1.30%)
Spherix, Inc. (SPEX)
CAPS Rating:
The Company operates via two principal segments, BioSpherix and InfoSpherix. BioSpherix develops proprietary products for commercial applications. InfoSpherix provides contact center information and reservation services for government and industry.
No one has written a Pitch for SPEX stock yet. Tell us why you think SPEX will outperform or underperform the S&P 500.

RSS Headlines
Fool UK